In terms of the use of prophylactic granulocyte colony-stimulating factor (G-CSF), a Cochrane systematic review demonstrated a substantial lack of data for the prevention of infections, prolongation of survival and improvement in QoL [26]. The gene discussed is CSF3; the disease is infection.